CGEM financials
Cullinan Therapeutics (CGEM) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CGEM income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$241.65M | -$219.88M | – |
| 2024 | – | – | -$196.92M | -$167.38M | – |
| 2023 | – | – | -$191.09M | -$153.16M | -3.69 |
| 2022 | $0.00 | – | $144.65M | $111.21M | 2.38 |
| 2021 | $18.94M | – | -$67.95M | -$65.57M | -1.52 |
| 2020 | $0.00 | – | -$60.34M | -$51.80M | -2.60 |